These analyses showed that the levels of KCTD3 and KCTD12 are increased in B-ALL while those of KCTD1 and KCTD11 are significantly enhanced in T-ALL patients (Figure 1D). Here, KCTD1 is linked to acute lymphoblastic leukemia.